Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Blank Check IPOs (SPACS) -- Ignore unavailable to you. Want to Upgrade?

To: Glenn Petersen who wrote (2043)	7/2/2009 7:34:04 AM
From: Glenn Petersen	Read Replies (1) \| Respond to of 3862

Pantheon China Acquisition Corp. (stock symbol: [t]PCQC[/t]) has closed on its acquisition of China Cord Blood Services, a blood bank operator in China. Pantheon China Acquisition Corp. Announces Shareholder Approval and Closing of Its Business Combination with China Cord Blood Services Corporation Press Release Source: China Cord Blood Services Corporation On Wednesday July 1, 2009, 11:48 am EDT BEIJING, July 1, 2009 (GLOBE NEWSWIRE) -- Pantheon China Acquisition Corp. ("Pantheon") (OTCBB:PCQC - News) announced today that its shareholders approved its Agreement and Plan of Merger, Conversion and Share Exchange by Pantheon, China Cord Blood Services Corporation ("CCBS") at Pantheon's special meeting of stockholders on June 29, 2009. Pantheon also announced today the closing of business combination transaction between Pantheon and CCBS which took place on June 30, 2009, and Pantheon has changed its name to China Cord Blood Corporation. China Cord Blood Corporation will continue to trade on the OTCBB under the symbol PCQC until its expected transition to a larger U.S. exchange is completed. China Cord Blood Corporation is now the largest cord blood bank operator in China, with exclusive licenses to operate in Beijing Municipality and Guangdong Province. The company offers storage services of umbilical cord blood stem cells from newborn babies. Ms Tina Zheng, Chairperson and Chief Executive Officer of China Cord Blood Corporation, stated, "This is an exciting and long-anticipated achievement in the development and expansion of our company. The business combination with Pantheon gives us enhanced resources to accelerate our growth in China and the Pan-Asian region as well as the listing platform that will help to facilitate our future growth strategies and further enhance China Cord Blood Corporation brand recognition in China where the government imposes a single child policy. As the leading cord blood bank services provider in China, we look forward to building our corporate profile in the U.S. capital markets while generating long-term benefits for all stakeholders." "China Cord Blood Corporation has an outstanding business model with a proven track record of growth, long-term visibility to revenues and cash flows, and established market leadership," said Mark D. Chen, Chairman, Chief Executive Officer and President of Pantheon. "We are confident that this transaction and China Cord Blood Corporation emergence as a U.S.-listed public company provides the foundation for continuing growth, value generation and shareholder returns." <snip> finance.yahoo.com

To: Glenn Petersen who wrote (2043)	7/2/2009 7:34:19 AM
From: Glenn Petersen	Respond to of 3862

Some of the Pearl Geoup bond holders have expressed their opposition to the Liberty Acquisition transaction: Pearl bondholders say will not support float Reuters Wed Jul 1, 2009 6:27pm EDT LONDON, July 1 (Reuters) - Bondholders in British insurer Pearl Group said on Wednesday they would not back a proposed re-listing of the group because of concerns over treatment of the bonds. Debt-laden Pearl on Monday said it would float on the London Stock Exchange by selling itself to Euronext-listed takeover vehicle Liberty Acquisitions (LIA.A), thus providing the group with 510 million pounds ($838 million) of new capital. [ID:nLT293015] The holders of the 500 million pounds of debt securities said they were concerned about a lack of information concerning the notes, of which the most recent coupon remains unpaid, and said they had not yet received a response from Pearl regarding its plans for the notes. "In light of its concerns, the noteholder group members consider that they would be unable to support or invest in any re-listing that Pearl Group may launch," the group wrote in a statement. Pearl, which is backed by entrepreneur Hugh Osmond, has total debt of about 3 billion pounds, most of which was taken out to finance its takeover of rival Clive Cowdery's previous venture, life assurance investor Resolution Plc. It already angered the bondholders when in March it deferred making a 33 million pound interest payment on bonds issued by Resolution. Pearl was not immediately available to comment on Wednesday. The group was quoted on the Times website as saying it was up to individual investors to decide whether to take part in a listing. A spokesman told the Times: "We have been in continuing dialogue with the bondholders and remain so. None of their rights have been affected." (Reporting by Victoria Bryan; Editing Bernard Orr) reuters.com